Home Companies Roche

Roche

Precision Medicine Platform Trial Aims to Develop Treatments for Rare Cancers
Companies

Precision Medicine Platform Trial Aims to Develop Treatments for Rare Cancers

Laura Cowen -
0
Spark Therapeutics Will Develop a New $575M Gene Therapy Center in Philadelphia
Cellular Therapeutics

Spark Therapeutics Will Develop a New $575M Gene Therapy Center in Philadelphia

0
Roche’s Genentech Taps Adaptimmune for T-Cell Therapy Collaboration that Could Top $3B
Companies

Roche’s Genentech Taps Adaptimmune for T-Cell Therapy Collaboration that Could Top $3B

0
Artificial Intelligence Can Help Improve Bowel Cancer Treatment
Artificial Intelligence

Artificial Intelligence Can Help Improve Bowel Cancer Treatment

0
Roche, Blueprint Medicines Target RET-Altered Cancers with $1.7B Partnership
Companies

Roche, Blueprint Medicines Target RET-Altered Cancers with $1.7B Partnership

0
Illumina Debuts Two New Sequencers, Inks Dx Deal with Roche
Companies

Illumina Debuts Two New Sequencers, Inks Dx Deal with Roche

0
Illumina Prevails Against Ariosa in UK Patent Infringement Case
Ariosa Diagnostics

Illumina Prevails Against Ariosa in UK Patent Infringement Case

0
Flatiron Health, Foundation Medicine Publish Study Validating Clinico-Genomic Database
Bioinformatics

Flatiron Health, Foundation Medicine Publish Study Validating Clinico-Genomic Database

0
FDA Approves Roche CDx for Breast Cancer Combination Therapy Developed with Celgene
Applications

FDA Approves Roche CDx for Breast Cancer Combination Therapy Developed with Celgene

0
Expanding into Gene Therapy, Roche Plans $4.8B Acquisition of Spark Therapeutics
Applications

Expanding into Gene Therapy, Roche Plans $4.8B Acquisition of Spark Therapeutics

0
123Page 1 of 3

Trending

X Chromosome-Linked Enzyme May Explain Women’s Higher Alzheimer’s Incidence

X Chromosome-Linked Enzyme May Explain Women’s Higher Alzheimer’s Incidence

Ginkgo Bioworks Acquires Circularis to Strengthen Advanced Therapeutic Capacity

Ginkgo Bioworks Acquires Circularis to Strengthen Advanced Therapeutic Capacity

Amyloid Plaques More Common in White People with Dementia

Amyloid Plaques More Common in White People with Dementia

Alexion, AstraZeneca Rare Disease Acquires LogicBio

Alexion, AstraZeneca Rare Disease Acquires LogicBio

Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.